Current business models have struggled to support early-stage drug development. In this
paper, we study an alternative financing model, the mega-fund structure, to fund drug …

With the increasing aging population in China, the public's emphasis on health has been on
the rise. Many innovative pharmaceutical companies have undertaken multiple rounds of …

In this thesis, we explore the use of data analytics to facilitate biomedical innovation with a
particular emphasis on the mismatch between the risk characteristics of biomedical projects …

生物医药创新转化需要由学术研究机构, 生物科技公司和大型制药企业分工协作共同推进,
这三者间通过技术和专利授权进行利益分配, 进而产生药品特许权费用. 特许权投资就是在此 …